See also this year's filing and all EDGAR filings for this company.
PDF Report 0001328143_2019_Adamas_Pharmaceuticals_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001328143, Adamas Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 228,373,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,652,000 |
| 3 | remainder_Assets | 2,789,000 |
| 4 | LiabilitiesCurrent | 24,276,000 |
| 5 | LiabilitiesNoncurrent | 120,653,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 633,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 348,116,544 |
| 9 | ResearchAndDevelopmentExpense | 44,386,830 |
| 10 | remainder_Expenses | 11,369,026 |
| 11 | remainder_Revenues | 22,772,651 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | -33,826 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 234,814,000 |
| 1 | Liabilities | 144,929,000 |
| 2 | Expenses | 404,505,400 |
| 3 | Revenues | 22,772,651 |
| 4 | StockholdersEquity | 89,885,000 |
| 5 | NetIncome | -381,732,749 |
| 6 | ComprehensiveNetIncome | -381,749,662 |
| 7 | BaseVar | 403,527,438 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.979 |
| 9 | EconomicCapitalRatio | 1.31 |
Edgar->Model Mapping
Feature Distribution
Change over Time
